Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:78:161-163.
doi: 10.1016/j.ejim.2020.06.010. Epub 2020 Jun 9.

SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy

Affiliations

SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy

Gregorio Paolo Milani et al. Eur J Intern Med. 2020 Aug.
No abstract available

Keywords: Asymptomatic carriers; COVID-19; Immunoglobulins; Nasal swab; SARS-CoV-2; UNICORN; Viral RNA.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests None.

Figures

Fig 1
Fig. 1
Upper panel. Venn diagram showing the number of asymptomatic subjects testing positive for SARS-CoV-2 for RNA in the nasal mid-turbinate (violet circle), for circulating IgM (red circle), IgG (green circle), and Total Ab (blue circle). Lower panel. Histogram showing the frequency and percentage of subjects testing positive for IgM, IgG and Total antibodies (Total Ab). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

References

    1. World Health Organization (WHO). WHO director-general's opening remarks at the media briefing on COVID-19: 11 March 2020. Published March 11, 2020. Accessed March 11, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
    1. Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020;369:m1375. - PubMed
    1. Centers for diseases control and prevention guideline for “collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)”, (2020). cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
    1. GeurtsvanKessel CH, OKBA NMA, Igloi Z, Embregts CWE, Laksono BM, et al. (2020) Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment. medRxiv: 2020.2004.2023.20077156.
    1. Lassaunière R, Frische A, Harboe ZB, Nielsen AC, Fomsgaard A, et al. (2020) Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv: 2020.2004.2009.20056325.

MeSH terms

Substances

LinkOut - more resources